Work

Abstract C056: Risk of Immune-related adverse events with immune checkpoint inhibitors in locally advanced nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials

Year: 2025

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-c056

Authors: Ramaditya Srinivasmurthy, Rishi K. Nanda, Daniel T. Jones, Taimur Khalid, Jason Ta, Kenny Do, Riccesha Hattin, Abbas Hussain, Yin M. Myat, Sisi Tian, Jo-Lawrence Bigcas, Kyaw Z. Thein

Institutions: Mount Sinai Hospital, Touro University Nevada, University of Nevada, Las Vegas, University of South Florida, HCA Healthcare, Interfaith Medical Center, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415449286

FWCI:

Cites:

Cited by:

Related to: